期刊
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
卷 134, 期 18, 页码 949-954出版社
GEORG THIEME VERLAG KG
DOI: 10.1055/s-0029-1220255
关键词
type 2 diabetes; pioglitazone; rosiglitazone; oral antidiabetic drugs; insulin; evidence; cardiovascular risk; comorbidities